Sophia Stock

17PUBLICATIONS
102CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Carbon capture engineering (excl. sequestration)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Feb 11, 2026
Ablation of prostaglandin E<sub>2</sub> signalling through dual receptor knockout in CAR T cells enhances therapeutic efficacy in solid tumours.

Janina Dörr, Lisa Gregor, Sebastian B Lacher

|Oct 22, 2025
Prognostic value of inflammation-based scores in patients with R/R LBCL treated with CD3×CD20 bispecific T-cell engagers.

Giulia Magno, Kai Rejeski, Giulia Rappa

|Apr 03, 2025
Dissection of single-cell landscapes for the development of chimeric antigen receptor T cells in Hodgkin lymphoma.

Adrian Gottschlich, Ruth Grünmeier, Gordon Victor Hoffmann

|Apr 01, 2025
Site-specific analysis of extranodal involvement in large B-cell lymphoma reveals distinct efficacy with chimeric antigen receptor T-cell therapy.

Gloria Iacoboni, Kai Rejeski, Víctor Navarro

|Apr 24, 2024
PGE<sub>2</sub> limits effector expansion of tumour-infiltrating stem-like CD8<sup>+</sup> T cells.

Sebastian B Lacher, Janina Dörr, Gustavo P de Almeida

|Sep 22, 2023
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion.

Kai Rejeski, Ariel Perez, Gloria Iacoboni

Pageof 3

Frequent Collaborators

9 joint publications

Sebastian Kobold

4 joint publications

Leopold Sellner

4 joint publications

Adrian Gottschlich

4 joint publications

Ruth Grünmeier